BTG slumps as it takes £150mln impairment for PneumRx Coils in full year results

04:53 EDT 5 Apr 2018 | Proactive Investors

BTG does not expect material revenues from PneumRx Coils over the next two years.

Original Article: BTG slumps as it takes £150mln impairment for PneumRx Coils in full year results

More From BioPortfolio on "BTG slumps as it takes £150mln impairment for PneumRx Coils in full year results"